Skip to main content

What the label lists and what reports show

Dextrose and potassium chloride side effects

Dextrose and potassium chloride's FDA label lists its adverse reactions in its own words. FAERS holds 92,110 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is diarrhoea (6,758 reports).

  • Generic listed

Check it at the source: the dextrose and potassium chloride FDA label on DailyMed (effective July 15, 2019, Baxter Healthcare Company); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

The following adverse reactions associated with the use of Potassium Chloride in Dextrose Injection were identified in post marketing reports. Because these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The following clinically significant adverse reactions are described elsewhere in the labeling: • Hypersensitivity reactions: including anaphylaxis and chills [see Warnings and Precautions (5.1) ]. …

Source: FDA drug label, Baxter Healthcare Company, effective July 15, 2019 (SPL set 45de5402-5e61-4bbd-8bbc-5e3392c9920e), via openFDA; the full label on DailyMed

What do FAERS reports show?

92,110 reports list dextrose and potassium chloride among the medicines taken, each a report of something that happened, not proof the medicine caused it; 13,521 are coded as a death and 42,525 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 22 reactions below, 5 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Dextrose and potassium chloride: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions